U.S. markets closed

Aspen Pharmacare Holdings Limited (APNHF)

Other OTC - Other OTC Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
12.000.00 (0.00%)
Al cierre: 09:48AM EDT

Aspen Pharmacare Holdings Limited

Aspen Place
9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge
Durban
South Africa
27 31 580 8600
https://www.aspenpharma.com

Sector(es)Healthcare
IndustriaDrug Manufacturers - Specialty & Generic
Empleados a tiempo completo8,612

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Stephen Bradley Saad BCom, CA(SA)Group CEO & Executive Director1.03MN/D1964
Mr. Sean M. CapazorioGroup CFO & Executive Director560.61kN/D1967
Ms. Lorraine HillGroup Chief Operations Officer & Responsible Pharmacist604.17kN/D1964
Mr. Michael Guy Attridge B.Com., CA(SA)Group Chief Advisor454.51kN/D1961
Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBAGroup Chief Corporate Services Officer & Executive Director422.91kN/D1975
Ms. Zizipho MmangoGroup Chief Strategic Development Officer422.85kN/D1985
Sibongakonke NkosiInvestor Relations ManagerN/DN/DN/D
Mr. Trevor Julian ZimanRegional Chief Executive Officer of Asia PacificN/DN/D1972
Mr. Samer KassemChief Executive Officer of Aspen Global IncorporatedN/DN/D1975
Ms. Raeesa KhanGroup Company SecretaryN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Gestión corporativa

La calificación ISS Governance QuickScore de Aspen Pharmacare Holdings Limited a partir del 1 de mayo de 2024 es 5. Las puntuaciones principales son Auditoría: 7; Junta: 4; Derechos del accionista: 2; Compensación: 6.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.